Literature DB >> 29470560

Renal artery revascularisation: can we predict who benefits?

Abhizith Deoker1, Debabrata Mukherjee1.   

Abstract

Keywords:  hypertension; peripheral vascular disease; renal stenting; renovascular disease

Year:  2017        PMID： 29470560      PMCID： PMC5818045          DOI： 10.1136/heartasia-2017-010951

Source DB:  PubMed          Journal:  Heart Asia        ISSN： 1759-1104


× No keyword cloud information.
  9 in total

1.  Renal artery end-diastolic velocity and renal artery resistance index as predictors of outcome after renal stenting.

Authors:  D Mukherjee; D L Bhatt; M Robbins; M Roffi; L Cho; J Reginelli; C Bajzer; F Navarro; J S Yadav
Journal:  Am J Cardiol       Date:  2001-11-01       Impact factor: 2.778

2.  Renal artery revascularization: is there a rationale to perform?

Authors:  Debabrata Mukherjee
Journal:  JACC Cardiovasc Interv       Date:  2009-03       Impact factor: 11.195

3.  ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC).

Authors:  Michal Tendera; Victor Aboyans; Marie-Louise Bartelink; Iris Baumgartner; Denis Clément; Jean-Philippe Collet; Alberto Cremonesi; Marco De Carlo; Raimund Erbel; F Gerry R Fowkes; Magda Heras; Serge Kownator; Erich Minar; Jan Ostergren; Don Poldermans; Vincent Riambau; Marco Roffi; Joachim Röther; Horst Sievert; Marc van Sambeek; Thomas Zeller
Journal:  Eur Heart J       Date:  2011-08-26       Impact factor: 29.983

4.  Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Lesley H Curtis; David DeMets; Robert A Guyton; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen
Journal:  Circulation       Date:  2013-03-01       Impact factor: 29.690

5.  Effect of renal artery revascularization on left ventricular hypertrophy, diastolic function, blood pressure, and the one-year outcome.

Authors:  Daniel Rzeznik; Tadeusz Przewlocki; Anna Kablak-Ziembicka; Artur Kozanecki; Agnieszka Roslawiecka; Jacek Lach; Wieslawa Tracz; Piotr Podolec
Journal:  J Vasc Surg       Date:  2010-12-03       Impact factor: 4.268

Review 6.  SCAI expert consensus statement for renal artery stenting appropriate use.

Authors:  Sahil A Parikh; Mehdi H Shishehbor; Bruce H Gray; Christopher J White; Michael R Jaff
Journal:  Catheter Cardiovasc Interv       Date:  2014-08-19       Impact factor: 2.692

7.  Missed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions: insights from the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2).

Authors:  Debabrata Mukherjee; Prasanth Lingam; Stanley Chetcuti; P Michael Grossman; Mauro Moscucci; Ann E Luciano; Kim A Eagle
Journal:  Circulation       Date:  2002-10-08       Impact factor: 29.690

8.  Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling.

Authors:  Andre Rudolph; Hassan Abdel-Aty; Steffen Bohl; Philipp Boyé; Anja Zagrosek; Rainer Dietz; Jeanette Schulz-Menger
Journal:  J Am Coll Cardiol       Date:  2009-01-20       Impact factor: 24.094

9.  Stenting and medical therapy for atherosclerotic renal-artery stenosis.

Authors:  Christopher J Cooper; Timothy P Murphy; Donald E Cutlip; Kenneth Jamerson; William Henrich; Diane M Reid; David J Cohen; Alan H Matsumoto; Michael Steffes; Michael R Jaff; Martin R Prince; Eldrin F Lewis; Katherine R Tuttle; Joseph I Shapiro; John H Rundback; Joseph M Massaro; Ralph B D'Agostino; Lance D Dworkin
Journal:  N Engl J Med       Date:  2013-11-18       Impact factor: 91.245
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.